Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure.

Sébert M, Renneville A, Bally C, Peterlin P, Beyne-Rauzy O, Legros L, Gourin MP, Sanhes L, Wattel E, Gyan E, Park S, Stamatoullas A, Banos A, Laribi K, Jueliger S, Bevan L, Chermat F, Sapena R, Nibourel O, Chaffaut C, Chevret S, Preudhomme C, Adès L, Fenaux P; Groupe Francophone des Myélodysplasies (GFM).

Haematologica. 2019 Aug;104(8):1565-1571. doi: 10.3324/haematol.2018.207118. Epub 2019 Feb 7.

2.

Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia.

Lehmann-Che J, Bally C, Letouzé E, Berthier C, Yuan H, Jollivet F, Ades L, Cassinat B, Hirsch P, Pigneux A, Mozziconacci MJ, Kogan S, Fenaux P, de Thé H.

Nat Commun. 2018 May 24;9(1):2047. doi: 10.1038/s41467-018-04384-5.

3.

NPM1 mutation is not associated with prolonged complete remission in acute myeloid leukemia patients treated with hypomethylating agents.

Prata PH, Bally C, Prebet T, Recher C, Venton G, Thomas X, Raffoux E, Pigneux A, Cluzeau T, Desoutter J, Gay J, Preudhomme C, Fenaux P, Adès L.

Haematologica. 2018 Oct;103(10):e455-e457. doi: 10.3324/haematol.2018.189886. Epub 2018 May 10. No abstract available.

4.

Genetic analysis of therapy-related myeloid neoplasms occurring after intensive treatment for acute promyelocytic leukemia.

Renneville A, Attias P, Thomas X, Bally C, Hayette S, Farhat H, Eclache V, Marceau-Renaut A, Cassinat B, Feuillard J, Terré C, Delabesse E, Park S, Lejeune J, Chevret S, Adès L, Preudhomme C, Fenaux P.

Leukemia. 2018 Sep;32(9):2066-2069. doi: 10.1038/s41375-018-0137-6. Epub 2018 Apr 18. No abstract available.

PMID:
29740159
5.

Favorable evolution of lung interstitial disease in a patient with chronic myelomonocytic leukemia treated with azacitidine.

Hilmi M, Bally C, Burns R, Lorillon G, Bergeron A, Fenaux P, Ades L.

Ann Hematol. 2018 Mar;97(3):541-542. doi: 10.1007/s00277-017-3190-8. Epub 2017 Nov 23. No abstract available.

PMID:
29170809
6.

Outcome of patients treated for myelodysplastic syndromes with 5q deletion after failure of lenalidomide therapy.

Prebet T, Cluzeau T, Park S, Sekeres MA, Germing U, Ades L, Platzbecker U, Gotze K, Vey N, Oliva E, Sugrue MM, Bally C, Kelaidi C, Al Ali N, Fenaux P, Gore SD, Komrokji R.

Oncotarget. 2017 Jun 14;8(47):81926-81935. doi: 10.18632/oncotarget.18477. eCollection 2017 Oct 10.

7.

[Documenting lifelong learning online].

Bally C, Ramseier P.

Krankenpfl Soins Infirm. 2015;108(10):22-3, 68-9, 84-5. French, German, Italian. No abstract available.

PMID:
26591915
9.

Comparison of TP53 mutations screening by functional assay of separated allele in yeast and next-generation sequencing in myelodysplastic syndromes.

Bally C, Renneville A, Preudhomme C, Legrand M, Adès L, de Thé H, Fenaux P, Lehmann-Che J.

Leuk Res. 2015 Jul 4. pii: S0145-2126(15)30344-1. doi: 10.1016/j.leukres.2015.07.001. [Epub ahead of print]

PMID:
26271412
10.

Bivalirudin as an adjunctive anticoagulant to heparin in the treatment of heparin resistance during cardiopulmonary bypass-assisted cardiac surgery.

McNair E, Marcoux JA, Bally C, Gamble J, Thomson D.

Perfusion. 2016 Apr;31(3):189-99. doi: 10.1177/0267659115583525. Epub 2015 May 1. Review.

PMID:
25934498
11.

Resistance to therapy in acute promyelocytic leukemia.

Lehmann-Che J, Bally C, de Thé H.

N Engl J Med. 2014 Sep 18;371(12):1170-2. doi: 10.1056/NEJMc1409040. No abstract available.

PMID:
25229938
12.

Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine.

Bally C, Adès L, Renneville A, Sebert M, Eclache V, Preudhomme C, Mozziconacci MJ, de The H, Lehmann-Che J, Fenaux P.

Leuk Res. 2014 Jul;38(7):751-5. doi: 10.1016/j.leukres.2014.03.012. Epub 2014 Mar 23.

PMID:
24836762
13.

Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): a report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM).

Bally C, Thépot S, Quesnel B, Vey N, Dreyfus F, Fadlallah J, Turlure P, de Botton S, Dartigeas C, de Renzis B, Itzykson R, Fenaux P, Adès L.

Leuk Res. 2013 Jun;37(6):637-40. doi: 10.1016/j.leukres.2013.02.014. Epub 2013 Mar 15.

PMID:
23499498
14.

A G polymorphism in the CRBN gene acts as a biomarker of response to treatment with lenalidomide in low/int-1 risk MDS without del(5q).

Sardnal V, Rouquette A, Kaltenbach S, Bally C, Chesnais V, Leschi C, Ades L, Santini V, Park S, Toma A, Fenaux P, Dreyfus F, Fontenay M, Kosmider O.

Leukemia. 2013 Jul;27(7):1610-3. doi: 10.1038/leu.2013.59. Epub 2013 Feb 26. No abstract available.

PMID:
23434730
15.

Spontaneous conception after autologous hematopoietic stem cell transplantation: a case report.

Dupont C, Bally C, Eustache F, Sermondade N, Benzacken B, Fenaux P, Lévy R.

Asian J Androl. 2013 Jan;15(1):155-6. doi: 10.1038/aja.2012.119. Epub 2012 Dec 10. No abstract available.

16.

Outcome of acute promyelocytic leukemia (APL) in children and adolescents: an analysis in two consecutive trials of the European APL Group.

Bally C, Fadlallah J, Leverger G, Bertrand Y, Robert A, Baruchel A, Guerci A, Recher C, Raffoux E, Thomas X, Leblanc T, Idres N, Cassinat B, Vey N, Chomienne C, Dombret H, Sanz M, Fenaux P, Adès L.

J Clin Oncol. 2012 May 10;30(14):1641-6. doi: 10.1200/JCO.2011.38.4560. Epub 2012 Apr 2.

PMID:
22473162
17.

[Eosinophilic pleural effusion related to taking valproic acid].

Bally C, Martin C, Kraoua S, Kanaan R, Lacronique J, Dusser D, Burgel PR.

Rev Pneumol Clin. 2011 Dec;67(6):363-6. doi: 10.1016/j.pneumo.2010.11.008. Epub 2011 Apr 29. French.

PMID:
22137281
18.

[Recurrent Staphylococcus aureus infections].

Bally C, Meyssonnier V, Bricaire F.

Med Mal Infect. 2011 Jun;41(6):346-8. doi: 10.1016/j.medmal.2010.12.019. Epub 2011 Mar 21. French. No abstract available.

PMID:
21420264
19.

Care of the bariatric patient. Health concerns after surgery.

Bally C, Blackburn P, Brown N.

Adv Nurse Pract. 2010 Jun;18(6):37-9. No abstract available.

PMID:
20575374
20.

[The French version of the FOUR score: A new coma score].

Weiss N, Mutlu G, Essardy F, Nacabal C, Sauves C, Bally C, Houbert M, Lecorre C, Germack V, Demeret S, Pierrot-Deseilligny C, Bolgert F.

Rev Neurol (Paris). 2009 Oct;165(10):796-802. doi: 10.1016/j.neurol.2009.01.045. Epub 2009 Mar 17. French.

PMID:
19296997
21.

[Activities of the consultant physician].

Bally C.

Rev Med Suisse Romande. 1996 Jul;116(7):561-4. French. No abstract available.

PMID:
8765573
22.

[Human insulin].

Fankhauser S, Bally C, Schönle E.

Schweiz Rundsch Med Prax. 1986 May 20;75(21):614-8. German. No abstract available.

PMID:
3523675
23.

[Cardiovascular risk factors: an intervention program for general practice].

Grüninger U, Weidmann P, Abelin T, Bally C, Howald H, Mordasini R, Hochstrasser B, Lüthy R, Roschi A.

Schweiz Med Wochenschr. 1984 Dec 1;114(48):1744-6. German.

PMID:
6523102
24.

[New diagnostic criteria in diabetes mellitus].

Bally C.

Ther Umsch. 1983 Oct;40(10):831-5. German. No abstract available.

PMID:
6648841
25.

[Immunological aspects of insulin-dependent diabetes (author's transl)].

Bally C.

Schweiz Rundsch Med Prax. 1979 Dec 11;68(50):1649-51. German. No abstract available.

PMID:
398490
26.

[Oral antidiabetics].

Bally C, Assal JP.

Ther Umsch. 1979 Nov;36(11):1000-3. German. No abstract available.

PMID:
538739
27.

HLA and DRW antigens in insulin-dependent diabetes.

de Moerloose P, Jeannet M, Bally C, Raffoux C, Pointel JP, Sizonenko P.

Br Med J. 1978 Apr 1;1(6116):823-4. No abstract available.

28.

[Teaching of diabetic patients: experiences in the United States and in Geneva (author's transl)].

Bally C, Assal J.

Schweiz Rundsch Med Prax. 1977 Nov 22;66(47):1495-8. German. No abstract available.

PMID:
918012
29.

Antibody activation of mutant human fructosediphosphate aldolase B in liver extracts of patients with hereditary fructose intolerance.

Gitzelmann R, Steinmann B, Bally C, Lebherz HG.

Biochem Biophys Res Commun. 1974 Aug 19;59(4):1270-7. No abstract available.

PMID:
4212946
30.

[Purification and properties of human liver aldolase. 19. Aldolases].

Gürtler B, Bally C, Leuthardt F.

Hoppe Seylers Z Physiol Chem. 1971 Oct;352(10):1455-62. German. No abstract available.

PMID:
5128320
31.

[Stereospecificity of alcohol dehydrogenase].

Bally C, Leuthardt F.

Helv Chim Acta. 1970;53(4):732-8. German. No abstract available.

PMID:
5433435
32.

[Studies on traffic adaptation of boys with defective color vision].

BALLY C.

Z Unfallmed Berufskr. 1954;47(2):100-9. German. No abstract available.

PMID:
13196527

Supplemental Content

Support Center